Injectable Egg-Free Influenza Vaccine 2027
Closed Pre-Solicitation Posted
Not the latest version. See the latest pre-solicitation from .
- Solicitation number
- SPE2DP26R0004
- Agency
-
Medical Supply Chain
Troop Support, Department of Defense
- Responses due
- Set-aside
- No set-aside
Opportunity facts
- NAICS code
- 325414 Biological Product (except Diagnostic) Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Place of performance
- United States
Notice details come from SAM.gov. Updated .
About this opportunity
The Defense Logistics Agency Troop Support intends to solicit an indefinite-quantity contract for the supply of injectable egg-free influenza vaccine for the 2027–2028 flu season, with a response deadline of September 7, 2026.
Approximately 300,000 doses are estimated annually, though quantities may increase or decrease based on final Service requirements. The guaranteed minimum will be 75 percent of the annual estimate, and the contract maximum will be established at 150 percent of the annual estimate. Vaccines must be supplied in prefilled syringes and delivered to Defense Depot New Cumberland, Pennsylvania. The contractor must meet a staggered delivery schedule: 40 percent of the requirement by August 12, 2027, 25 percent by August 26, 2027, 25 percent by September 9, 2027, and the remaining 10 percent by September 23, 2027. Alternative delivery schedules may be considered.
The vaccine must be FDA-approved for immunizing individuals 18 years and older. The successful contractor must hold FDA approval, and the vaccine must be CDC Advisory Committee on Immunization Practices (ACIP) recommended. The 2027–2028 formula will be determined by the FDA Vaccines and Related Biological Products Advisory Committee.
National Stock Numbers will be established at the time of award. The solicitation will be posted to the DLA Bid Board System and SAM.gov. Interested parties should contact Rosbert Jones at 445-737-1254 or Rosbert.Jones@dla.mil with questions.
Notice text
The Defense Logistics Agency Troop Support is soliciting for the supply of Injectable Egg-Free Influenza Vaccine for the 2027-2028 flu season. Approximately 300,000 doses are included in this requirement. (Quantities may increase or decrease pending receipt of final Service requirements.) The vaccines shall be in prefilled syringes presentation. The vaccine shall be FDA-approved for immunizing individuals 18 years and older.
The formula for the 2027-2028 season shall be determined by the U.S. Food & Drug Administration (FDA) Vaccines and Related Biological Products Advisory Committee. Other specification data is included in the solicitation. Successful contractor must have FDA Approval, and the vaccine must be U.S. Centers for Disease Control and Prevention (CDC) Advisory Committee on Immunization Practices (ACIP) recommended. National Stock Numbers shall be established at the time of award.
An indefinite quantity contract is proposed. The quantity indicated is an annual estimate only. The guaranteed minimum will be 75% of the annual estimate, and a contract maximum will be established at 150% of the annual estimate.
Ordered quantities shall be delivered to the Defense Depot New Cumberland, PA. The contractor shall be capable of delivering 40% of the requirement by August 12, 2027, 25% by August 26, 2027, 25% by September 9, 2027, and the residual 10% by September 23, 2027. The Delivery Schedule shall apply to the estimated annual quantity. This delivery schedule is the preferred delivery schedule. Other delivery schedules may be considered.
A copy of the solicitation will be posted to the DLA Bid Board System (DIBBS) at https://www.dibbs.bsm.dla.mil and SAM.gov at https://www.sam.gov. Interested parties should contact Rosbert Jones (445-737-1254) (Rosbert.Jones@dla.mil) for any questions/comments. Interested parties are further advised to set up automated notifications of presolicitation or solicitation changes through this website. The current projected solicitation date is October of 2026. DLA reserves the right to issue the solicitation before or after the projected solicitation date.
Notice history
| Notice | Type | Posted |
|---|---|---|
| Injectable Egg-Free Influenza Vaccine 2027 | Pre-Solicitation | |
| This notice | Pre-Solicitation |
Similar open opportunities
| Opportunity | Agency | Set-aside | Responses due |
|---|---|---|---|
| Request for Proposals (RFP) - BARDA Vaccine Medical Countermeasures for Pandemic Influenza Preparedness & Response | Office of the Assistant Secretary for Preparedness and Response | No set-aside | |
| Epinephrine Injector | Medical Supply Chain | No set-aside |
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity